Brief: India's Titan Biotech March Qtr Consol Profit Rises
29/05/2018 13:19
May 29 (Reuters) - Titan Biotech Ltd TITM.BO :
* MARCH QUARTER CONSOL PROFIT 13.2 MILLION RUPEES VERSUS
8.8
MILLION RUPEES YEAR AGO
* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 150.7 MILLION
RUPEES VERSUS 150.6 MILLION RUPEES YEAR AGO
Source text: http://bit.ly/2JjS0se
Further company coverage: TITM.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Biotech
See all newsBrief: Titan Biotech's Board Approves Issuance Of Bonus Shares In Ratio Of 1:4
Brief: Titan Biotech Says Ngenious Solutions Initiates Arbitration Against Titan Biotech
Brief: India's Titan Biotech To Consider Preferential Issue Of Equity Shares
Brief: India's Titan Biotech June Qtr Consol Profit Rises
Brief: India's Titan Biotech March Qtr Consol Profit Rises